Immune-based therapies are expanding #Melanoma treatment options. Learn more in this #PeerView activity, featuring Hussein Tawbi, MD, PhD (Hussein Tawbi, MD, PhD) and Prof. Christian Blank, MD, PhD, who will discuss #ASCO2024 updates bit.ly/457XspU

A 3-year survival update on RELATIVITY-047 comparing nivolumab + relatlimab vs nivolumab in previously untreated metastatic or unresectable stage III or IV melanoma. Hussein Tawbi, MD, PhD MD Anderson Cancer Center #melsm onclive.com/view/nivolumab…

Thank you ABC News for the opportunity to discuss this important study and to highlight the role of cancer research to better understand incidence patterns, risk factors, and opportunities to improve patient outcomes

So so amazing to witness this mind-blowing achievement in 2 years!.. I have seen u move mountains to support your team(s) and never falter as u accomplished this “side quest” (in ur own words) & did it w such grace, confidence, wisdom, & insight, all qualities that u define.

“Mind-blowing” is the best way to describe the most innovative and exciting Brain Mets/LMD meeting - thank you #snoasco24 for putting this on! Kicking off the meeting with inspiring words by Daphne Haas-Kogan Hussein Tawbi, MD, PhD and Dr. Priya Kumthekar and being energized by the LMD Think Tank

Poster session success at #SNOASCO24! Thanks to everyone who stopped by the CIMARa poster to learn more about our collaborative group. To those who stopped by the #MetsGetsAwareness poster, sorry I didn't get to talk with you but happy to chat anytime about this campaign!

Remember how excited I was when our amazing research nurse supervisor Suzanne Phillips at MD Anderson Cancer Center took the stage? She is at it again and presenting initial data for one of our brain mets trials! Wonderful to see my team members taking the stage at #snoasco24! Hussein Tawbi, MD, PhD

Deep dive into the practicalities and barriers to bringing innovations to pts with brain mets and LMD at the 2024 SNO/ASCO CNS Metastases Conference Tatiana Prowell, MD Carey Anders Hussein Tawbi, MD, PhD

Energizing and inspiring #snoasco24 - congrats to Hussein Tawbi, MD, PhD and Priya Kumthekar on a most successful #CNSmets meeting! Congrats also to Emanuela Ferraro on her #WinHER2 update SNO ASCO

“Elevating Chemistry” is the theme for the #ACSFall2024. Despite all hurdles & obstacles, our #TrEd American University of Beirut has been elevating chemistry, students, & the community for more than 13 years now… Will be giving a talk about our TrEd in 2 hrs & a research talk on Tuesday. #TrEd

Huge congratulations to all my MD Anderson Cancer Center colleagues who are funded by CPRIT today. From high risk high reward awards (Wen Jiang MD, PhD) all the way to advanced spatial genomics core facility (Nicholas Navin) & everything in between! 🙌🏽 cprit.texas.gov/news-events/ar…

Our Dr. Hussein Tawbi participates in a round table discussion of parnivolumab/ipilimumab versus nivolumab/relatlimab for a patient with metastatic melanoma: brnw.ch/21wMbyt Hussein Tawbi, MD, PhD #Melanoma #EndCancer

During a Case-Based Roundtable® event, Hussein A. Tawbi, MD, PhD, and participants considered nivolumab/ipilimumab and nivolumab/relatlimab as options for a patient with metastatic melanoma.